{
      "ptx_code": "PTX183",
      "chem_name": "Adefovir dipivoxil",
      "casrn": "142340-99-6",
      "dtxsid": "DTXSID5046487",
      "smiles": "CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C",
      "inchikey": "WOZSCQDILHKSGG-UHFFFAOYSA-N",
      "label": "PTX183 | Adefovir dipivoxil",
      "drugbank_id": "DB00718",
      "use_class": "Pharmaceutical",
      "tox_class": "Hepatotoxicity; Nephrotoxicity",
      "chem_name_user": "Adefovir dipivoxil",
      "mw_g_mol": "501.48",
      "solubility_h2o_mol_liter": "4.84e-04",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "2.31e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.03",
      "source_kaw": "LSER",
      "pka_acid": "",
      "pka_base": "3.58",
      "source_pka": "ACD/GALAS",
      "log_kow_liter_liter": "1.06",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "1.20",
      "source_dlipw": "Kow QSAR (\u2206mw = 1)",
      "freely_dissolved_fraction": "0.94",
      "density_kg_liter": "1.57",
      "source_density": "COMPTOX",
      "average_mass": "501.48",
      "boiling_point": "641.0 \u00b0C",
      "source_boiling_point": "Biosynth (Chemical company)",
      "melting_point": "101.0 \u00b0C",
      "source_melting_point": "Tokyo Chemical Industry (Chemical company)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "10871.93",
      "baseline_dmagna": "3463.91",
      "baseline_celegans": "7612.43",
      "baseline_xlaevis": "1427.22",
      "baseline_dmelanogaster": "31295.84",
      "baseline_cells": "1.76e-03",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.66e-03",
      "moa_drugbank": "Adefovir dipivoxil is a prodrug of adefovir. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA. The inhibition constant (Ki) for adefovir diphosphate for HBV DNA polymerase was 0.1 &mu;M. Adefovir diphosphate is a weak inhibitor of human DNA polymerases &alpha; and &gamma; with Ki values of 1.18 &mu;M and 0.97&mu;M, respectively.",
      "protein_binding": "&le;4% over the adefovir concentration range of 0.1 to 25 &mu;g/mL",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            }
      ],
      "targets": []
}